AIB1 as an Independent Prognostic Marker in Hepatocellular Carcinoma After Hepatic Resection

被引:0
|
作者
Jun-Min Song
Min Lu
Fang-Fang Liu
Xiao-Juan Du
Bao-Cai Xing
机构
[1] Peking University School of Oncology,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Hepatic, Biliary, and Pancreatic Surgery Unit I
[2] Beijing Cancer Hospital and Institute,Department of Pathology
[3] Peking University Health Science Center,Department of Genetics
[4] Peking University School of Oncology,Department of Cell Biology
[5] Beijing Cancer Hospital and Institute,Cancer Research Center
[6] Peking University Health Science Center,undefined
[7] Peking University Health Science Center,undefined
来源
关键词
Hepatocellular carcinoma; Amplified in breast cancer 1; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:356 / 360
页数:4
相关论文
共 50 条
  • [1] AIB1 as an Independent Prognostic Marker in Hepatocellular Carcinoma After Hepatic Resection
    Song, Jun-Min
    Lu, Min
    Liu, Fang-Fang
    Du, Xiao-Juan
    Xing, Bao-Cai
    JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (02) : 356 - 360
  • [2] Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival
    Luo, Jun-Hang
    Xie, Dan
    Liu, Meng-Zhong
    Chen, Wei
    Liu, Yong-Dong
    Wu, Guo-Qing
    Kung, Hsiang-Fu
    Zeng, Yi-Xin
    Guan, Xin-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (11) : 2554 - 2561
  • [3] Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma
    Zhang, Ju-Bo
    Zhang, Bo
    Guo, Lei
    Lin, Zhen-Hai
    Li, Xiao-Qiang
    Guo, Kun
    Sun, Hui-Chuan
    Ye, Qing-Hai
    ONCOTARGET, 2015, 6 (37) : 40223 - 40234
  • [4] Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma
    Dai, Xiao-Meng
    Huang, Tao
    Yang, Sheng-Li
    Zheng, Xiu-Mei
    Chen, George G.
    Zhang, Tao
    DISEASE MARKERS, 2017, 2017
  • [5] P53 immunohistochemical scoring:an independent prognostic marker for patients after hepatocellular carcinoma resection
    Lun-Xiu Qin Zhao-You Tang Zeng-Chen Ma Zhi-Quan Wu Xin-Da Zhou Qing-Hai Ye Yuan Ji Li-Wen Huang Hu-Liang Jia Hui-Chuan Sun Lu Wang
    World Journal of Gastroenterology, 2002, 8 (03) : 459 - 463
  • [6] P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
    Qin, LX
    Tang, ZY
    Ma, ZC
    Wu, ZQ
    Zhou, XD
    Ye, QH
    Ji, Y
    Huang, LW
    Jia, HL
    Sun, HC
    Wang, L
    WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (03) : 459 - 463
  • [7] Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis
    Nagasue, N
    Ono, T
    Yamanoi, A
    Kohno, H
    El-Assal, ON
    Taniura, H
    Uchida, M
    BRITISH JOURNAL OF SURGERY, 2001, 88 (04) : 515 - 522
  • [8] ANDROGEN RECEPTOR IN HEPATOCELLULAR-CARCINOMA AS A PROGNOSTIC FACTOR AFTER HEPATIC RESECTION
    NAGASUE, N
    CHANG, YC
    HAYASHI, T
    GALIZIA, G
    KOHNO, H
    NAKAMURA, T
    YUKAYA, H
    ANNALS OF SURGERY, 1989, 209 (04) : 424 - 427
  • [9] The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor
    Alkner, S.
    Bendahl, P. O.
    Grabau, D.
    Malmstrom, P.
    Ferno, M.
    Ryden, L.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1244 - 1252
  • [10] Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: Risk factors and prognostic analysis
    Yeh, CN
    Chen, MF
    WORLD JOURNAL OF SURGERY, 2004, 28 (04) : 382 - 386